BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 25, 2003
View Archived Issues
Chiron acquires rights to aerosolized ciclosporin from Novartis
Read More
Methods of detecting and treating cancer based on the Septin9 (MSF) gene
Read More
Bridged ketolides designed at Enanta to overcome bacterial resistance
Read More
New data suggest a role for statins in the treatment of Alzheimer's disease
Read More
ALA reported to improve neuropathic symptoms in diabetes
Read More
Procter & Gamble describes new inhibitors of cytokine production
Read More
Tyrosine kinase inhibitors and their use in cancer, angiogenesis, etc., claimed by Allergan
Read More
Yissum patent covers new agents for cancer, lipid storage disorders
Read More
Novel tryptase inhibitors under study at Boehringer Ingelheim
Read More
Cannabinoid CB1 antagonists in early development at Solvay
Read More
BMS researchers discover new inhibitors of MMP, TACE and/or aggrecanase
Read More
U.S./Japanese group identifies elastase release inhibitors
Read More
Erythromycin antibiotics prepared and tested at Ortho-McNeil
Read More
Novartis claims novel ACE/NEP inhibitors with utility in hypertension therapy
Read More
Teijin and Kyorin abandon business integration plans
Read More
Preliminary results from phase III trial of RSR-13 in brain metastases
Read More
Phase III RESIST trials begin for tipranavir
Read More
FDA approves Enteryx technology for GERD
Read More
Liprostin trial planned in critical limb ischemia and intermittent claudication
Read More
Indevus licenses rights to aminocandin
Read More
Cinacalcet demonstrates efficacy in dialysis patients with elevated parathyroid hormone
Read More
Enrollment completed in phase II study of ThGRF
Read More
Texas Biotechnology acquires Icos interest in partnership
Read More
NIH licensing opportunity: methods of inhibiting amino acid formation and tumor angiogenesis
Read More
Benzoylalkylindolepyridinium compounds for HIV available from NIH
Read More
Potential new immunosuppressant for use in transplantation isolated from Chinese herbs
Read More
Another major launch announced for Crestor
Read More